Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride-Reference-Cited by-同舟云学术

Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride

Published:2022-05-16 Issue:5 Volume:23 Page:
ISSN:1530-9932
Container-title:AAPS PharmSciTech
language:en
Short-container-title:AAPS PharmSciTech

Author:

Zhang Ting,Li Meng,Han Xiaolu,Nie Guangjun,Zheng Aiping

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics

Link

https://link.springer.com/content/pdf/10.1208/s12249-022-02252-6.pdf

Reference30 articles.

1. Coussens NP, Sittampalam GS, Jonson SG, et al. The opioid crisis and the future of addiction and pain therapeutics. J Pharmacol Exp Ther. 2019;371(2):396–408. https://doi.org/10.1124/jpet.119.259408.

2. United States Government Accountability Office. Synthetic opioids: considerations for the class-wide scheduling of fentanyl-related substances. GAO@100. 2021. https://www.gao.gov/products/gao-21-499. Published: Apr 12, 2021.

3. Public Health Agency of Canada. Apparent opioid and stimulant toxicity deaths. 2021. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/. Published: December 2021.

4. Skolnick P. On the front lines of the opioid epidemic: rescue by naloxone. Eur J Pharmacol. 2018;835:147–53. https://doi.org/10.1016/j.ejphar.2018.08.004.

5. Yeung DT, Bough KJ, Harper JR, Platoff GE Jr. National Institutes of Health (NIH) Executive meeting summary: developing medical countermeasures to rescue opioid-induced respiratory depression (a trans-agency scientific meeting)-August 6/7, 2019. J Med Toxicol. 2020;16(1):87–105. https://doi.org/10.1007/s13181-019-00750-x.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases;Journal of Controlled Release;2024-02

2. Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humans;Expert Opinion on Drug Metabolism & Toxicology;2023-10-03

3. Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers;Pharmaceutics;2023-08-10

4. Paclitaxel Delivery to the Brain for Glioblastoma Treatment;International Journal of Molecular Sciences;2023-07-21

5. Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest;Anesthesiology;2023-07-04